Patient demographics, disease duration, reasons for surgery, treatment, and total synovial scores for the 14 patients.
| Patient | Sex | Age at Time of Biopsy, yrs | Disease Duration, yrs | Reason for Surgery | Treatment | Synovial Score | DAS28 |
|---|---|---|---|---|---|---|---|
| 1 | F | 49 | 8 | Carpal tunnel release | ADA, MTX | 8 | 2.4 |
| 2 | F | 67 | 2 | Suspected giant cell tumor of tendon sheath | MTX, HCQ | 13 | 2.1 |
| 3 | M | 63 | 3 | Distal ulna hemi resection | MTX, HCQ | 12 | 2.3 |
| 4 | F | 47 | 20 | Shoulder arthroplasty | ETN | 5 | 2.5 |
| 5 | F | 46 | 1 | TKR | MTX | 18 | 2.6 |
| 6 | F | 53 | 1 | Left TKR | MTX | 17 | 2.6 |
| 6 | F | 53 | 1 | Right TKR | MTX | 12 | 2.4 |
| 7 | F | 73 | 2 | THR | MTX | 15 | 2.4 |
| 8 | F | 62 | 7 | Repair of FPL tendon rupture | MTX, PRED | 12 | NA |
| 9 | F | 60 | 2 | TKR | ETN, MTX | 9 | 2.5 |
| 10 | F | 67 | 2 | TKR | SSZ, HCQ, PRED | 20 | NA |
| 11 | F | 63 | 20 | Arthroscopy for persistent elbow swelling | ADA | 11 | 2.9 |
| 12 | M | 71 | 3 | THR | MTX | 3 | 2.1 |
| 13 | F | 61 | 20 | Carpal tunnel release | MTX, HCQ | 18 | 2.3 |
| 14 | F | 60 | 3 | Carpal tunnel release | MTX, HCQ | 9 | 2.6 |
DAS28: Disease Activity Score at 28 joints; ADA: adalimumab; MTX: methotrexate; HCQ: hydroxychloroquine; ETN: etanercept; TKR: total knee replacement; FPL: flexor pollicis longus; PRED: prednisone; SSZ: sulfasalazine; THR: total hip replacement; NA: not available.